Molecure S.A.
MOC.WA · WSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | PLN 2,919 | PLN 0 | PLN 7,513 | PLN 0 |
| % Growth | 2,919,000% | -100% | 1,878,262.3% | – |
| Cost of Goods Sold | PLN 3,409 | PLN 4,102 | PLN 1,635 | PLN 2,773 |
| Gross Profit | -PLN 490 | -PLN 4,102 | -PLN 21 | -PLN 2,773 |
| % Margin | -16.8% | -4,101,610% | -0.3% | -693,272.5% |
| R&D Expenses | PLN 2,356 | PLN 2,719 | PLN 11,625 | PLN 2,589 |
| G&A Expenses | PLN 0 | PLN 0 | PLN 6,028 | PLN 4,026 |
| SG&A Expenses | PLN 27,062 | PLN 4,711 | PLN 4,602 | PLN 2,650 |
| Sales & Mktg Exp. | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Other Operating Expenses | PLN 2,394 | PLN 20,597 | PLN 31 | PLN 27 |
| Operating Expenses | PLN 31,812 | PLN 28,026 | PLN 16,258 | PLN 5,266 |
| Operating Income | -PLN 33,609 | -PLN 32,128 | -PLN 43,908 | -PLN 13,764 |
| % Margin | -1,151.3% | -32,128,045% | -584.4% | -3,441,074.8% |
| Other Income/Exp. Net | PLN 2,321 | PLN 3,755 | PLN 7,957 | PLN 128 |
| Pre-Tax Income | -PLN 31,288 | -PLN 28,373 | -PLN 35,951 | -PLN 13,636 |
| Tax Expense | PLN 0 | PLN 0 | -PLN 1,724 | PLN 6 |
| Net Income | -PLN 31,288 | -PLN 28,373 | -PLN 13,540 | -PLN 13,643 |
| % Margin | -1,071.8% | -28,373,117% | -180.2% | -3,410,639% |
| EPS | -1.55 | -1.69 | -2.56 | -0.98 |
| % Growth | 8.3% | 34% | -161.2% | – |
| EPS Diluted | -1.55 | -1.69 | -2.56 | -0.98 |
| Weighted Avg Shares Out | 20,203 | 16,836 | 14,030 | 13,952 |
| Weighted Avg Shares Out Dil | 20,203 | 16,836 | 14,030 | 13,952 |
| Supplemental Information | – | – | – | – |
| Interest Income | PLN 1,125 | PLN 4,386 | PLN 1,911 | PLN 0 |
| Interest Expense | PLN 94 | PLN 89 | PLN 16 | PLN 6 |
| Depreciation & Amortization | PLN 3,820 | PLN 2,826 | PLN 3,984 | PLN 300 |
| EBITDA | -PLN 27,374 | -PLN 25,506 | -PLN 31,849 | -PLN 13,330 |
| % Margin | -937.8% | -25,505,806% | -423.9% | -3,332,504.8% |